For years, Exercise Oncology advocates have argued that structured exercise should become a standard component of cancer care because of its potential to improve outcomes, restore function, and enhance survivorship. The newly published cost-utility analysis from the landmark CHALLENGE trial adds another powerful message:
Exercise after colon cancer treatment is not simply beneficial—it may actually save healthcare dollars while improving survival and quality of life.
The Big Question: Can Exercise Be Affordable Enough to Become Standard Care?
The original CHALLENGE trial established that a 3-year structured exercise program following surgery and adjuvant chemotherapy improved outcomes for patients with stage III and high-risk stage II colon cancer.
This follow-up economic analysis asked an equally important question:
If exercise improves outcomes, can health systems afford to provide it?
The answer was striking.
Researchers evaluated 889 patients and compared a structured exercise program (SEP) delivered by trained exercise professionals with standard health education materials alone.
What Did They Find?
The structured exercise program produced:
- Lower overall healthcare costs
- Improved survival
- Higher quality-adjusted life years (QALYs)
Over five years:
- Exercise participants incurred approximately $1,589 less in total healthcare costs per person
- Gained approximately 0.05 additional life-years
- Achieved approximately 0.10 additional quality-adjusted life years (QALYs)
In health economics, this is called a dominant intervention—an uncommon result meaning the treatment is both more effective and less expensive.
Why Did Exercise Save Money?
The exercise program itself required investment—about $2,917 per participant to deliver.
But those upfront costs were offset by reductions in:
- Cancer recurrence and new malignancies
- Anticancer treatment costs
- Downstream healthcare utilization
The greatest savings came from preventing costly events later in survivorship.
This finding aligns directly with a central CancerFitness.org principle:
Exercise is not merely rehabilitation—it may function as a therapeutic adjunct capable of improving long-term cancer outcomes while reducing the burden of future care.
Why This Matters for Exercise Oncology
This publication moves Exercise Oncology into a new era.
Historically, exercise programs have often been viewed as supportive services that require outside funding or philanthropy.
CHALLENGE reframes the discussion.
If structured exercise:
- improves disease-free survival,
- improves overall survival,
- enhances quality of life,
- and reduces total healthcare expenditures—
Then Exercise Oncology deserves consideration as core cancer treatment infrastructure.
For cancer centers, insurers, policymakers, and healthcare systems, the question becomes:
Can we afford not to implement Exercise Oncology programs?
CancerFitness.org Call to Action
Cancer survivors should not have to discover therapeutic exercise on their own.
CancerFitness.org believes that every eligible patient should have access to evidence-based Exercise Oncology programs delivered by qualified professionals.
Now that Exercise Oncology is demonstrating:
- clinical benefit,
- survivorship benefit,
- and economic value—
It is time to move from proof of concept to routine implementation.
Exercise should no longer be considered optional supportive care. It should become part of how we treat cancer.
Reference: Structured exercise program following adjuvant chemotherapy for colon cancer: A cost3 utility analysis of the CHALLENGE trial. Kelvin KW. Chan, M.D., Ph.D., Ryan WK. Chu, M.Sc., M.B., B.Ch., B.A.O, Matthew C. Cheung, M.D., Kerry S. Courneya, Ph.D., et al. J Clin Oncol 10.1200/JCO-26-00765. Epub 2026
